PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks

Insights into ASX Stocks

NEXTDC (ASX: NXT)

NEXTDC (ASX: NXT): Stalled Grid Upgrade Makes A$8.7B Liquidity the Primary Safety Net

Oct 22, 2026
Proactive Equities Team

NEXTDC (ASX: NXT) has cut its FY27 guidance after Jemena suspended grid works at its Melbourne M3 data centre, deferring contracted revenue into FY28, while the company pauses uncontracted projects and reviews its capital spending plans.

SomnoMed (ASX: SOM)

SomnoMed (ASX: SOM): Jumps 23% From Yearly Low as Europe Reset Tests Growth Story

Oct 21, 2026
Proactive Equities Team

SomnoMed (ASX: SOM) shares jumped 23% to $0.29 near their yearly low, as the sleep apnoea device maker weighs a European reimbursement reset against North American growth and wider margins after FY26 EBITDA rose 19%.

Overwatch Technologies (ASX: OWL)

Overwatch Technologies (ASX: OWL): IPO Puts Maritime Surveillance Growth Prospects in Focus

Oct 21, 2026
Proactive Equities Team

Overwatch Technologies (ASX: OWL) has raised A$8 million through its IPO to advance its maritime surveillance technology, with future growth depending on government contracts, commercialisation and its ability to convert early customer activity into sustained revenue.

Gulf Stream Energy (ASX: GSE)

Gulf Stream Energy (ASX: GSE): Directors Put Fresh Cash behind Oil Push

Oct 21, 2026
Proactive Equities Team

Gulf Stream Energy (ASX: GSE) directors Eduardo Robaina, Joseph Graham and Troy Warrick converted performance rights and joined the October placement at $0.0045, buying roughly 15.9 million shares as the small explorer reports US oil discoveries.

Black Canyon (ASX: BCA)

Black Canyon (ASX: BCA): Option Expiry and AGM Put Capital Structure in Focus

Oct 21, 2026
Proactive Equities Team

Black Canyon (ASX: BCA) has issued new shares following option exercises, recorded the expiry of unexercised options, and outlined key resolutions for its November AGM, including a proposed 10% placement capacity to fund Wandanya Project development.

Alterity Therapeutics (ASX: ATH)

Alterity Therapeutics (ASX: ATH): New ATH434 Analysis Strengthens Case for Phase 3 Development

Oct 21, 2026
Proactive Equities Team

Alterity Therapeutics (ASX: ATH) reported an adjusted Phase 2 analysis showing ATH434 slowed functional decline by about 52% versus placebo at Week 52, as the company advances Phase 3 planning and evaluates funding needs.

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

12345...82
Page 4 of 82